Published in Fiziol Zh SSSR Im I M Sechenova on December 01, 1980
Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerontology (1980) 1.20
Have the oldest old adults ever been frail in the past? A hypothesis that explains modern trends in survival. J Gerontol A Biol Sci Med Sci (2001) 1.14
Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets (2011) 1.12
[Effect of buformin and diphenylhydantoin on the life span, estrous function and spontaneous tumor incidence in rats]. Vopr Onkol (1980) 0.94
[Current approaches to the study of carcinogenic safety, antineoplastic, anticarcinogenic and geroprotective effects of various pharmacologic preparations]. Vopr Onkol (2012) 0.92
Hypothalmic mechanisms of ageing and of specific age pathology--I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol (1979) 0.91
Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin). Cancer Lett (1979) 0.88
Promotion of skin tumors by 12-O-tetradecanoylphorbol-13-acetate in two generations of descendants of male mice exposed to X-ray irradiation. Mutat Res (1993) 0.88
[Effect of fenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats]. Vopr Onkol (1980) 0.87
Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging. Biochemistry (Mosc) (2014) 0.87
Melatonin and metformin inhibit skin carcinogenesis and lipid peroxidation induced by benz(a)pyrene in female mice. Bull Exp Biol Med (2011) 0.86
The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett (2001) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Carcinogenesis and aging. III. The role of age in initiation and promotion of carcinogenesis. Exp Pathol (1982) 0.84
[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84
[The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives]. Vopr Onkol (2009) 0.83
[Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice]. Vopr Onkol (2010) 0.83
Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the vagina, uterus and oviduct. IARC Sci Publ (1990) 0.83
[Metformin slows down ageing processes at the cellular level in SHR mice]. Tsitologiia (2011) 0.82
Carcinogenesis and aging. Adv Cancer Res (1983) 0.82
[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82
[Poly(ADP-ribosa)polymerase--the relationships with life span and carcinogenesis]. Adv Gerontol (2007) 0.81
[Inhibition of the blastomogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, diphenin, a polypeptide pineal extract and L-DOPA]. Biull Eksp Biol Med (1980) 0.80
Carcinogenesis and aging. I. Modifying effects of aging on N-methyl-N-nitrosourea-induced carcinogenesis in female rats. Exp Pathol (1981) 0.80
Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett (1999) 0.80
K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors. Cancer Lett (1996) 0.80
[Light-dark conditions, melatonin and risk of cancer]. Vopr Onkol (2006) 0.80
[Increase in longevity and a decrease in the frequency of tumors in C3H/Sn mice under the influence of fenformin and diphenin]. Dokl Akad Nauk SSSR (1979) 0.79
[Metformin effect on urethane-induced tumorigenesis in mice]. Vopr Onkol (2012) 0.79
[Phenformin elimination of the immunodepression caused by 1,2-dimethylhydrazine in rats]. Vopr Onkol (1977) 0.79
[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79
Dose-dependent inhibitory effect of melatonin on carcinogenesis induced by benzo[a]pyrene in mice. J Exp Clin Cancer Res (2006) 0.79
[Effect of an epiphyseal polypeptide preparation on life expectancy and frequency of spontaneous tumors in aged female rats]. Dokl Akad Nauk SSSR (1991) 0.78
[Melatonin inhibits urethane-induced carcinogenesis tumors in murine lung]. Vopr Onkol (2006) 0.78
[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
[An increase in hypothalamic sensitivity to the inhibiting effects of estrogens caused by use of L-DOPA, diphenine, epithalamin and phenformin in old rats]. Biull Eksp Biol Med (1975) 0.78
[Blood estradiol level and G2-chalone content in the vaginal mucosa in rats of different ages]. Probl Endokrinol (Mosk) (1981) 0.78
Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the comet assay. Mutat Res (1998) 0.78
The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats. Carcinogenesis (1980) 0.78
[Age dynamics of angiogenesis markers in transgenic HER-2/neu (FBV/N) mammary adenocarcinoma-prone mice]. Vopr Onkol (2015) 0.78
Persistence of methylated purines in the DNA of various rat fetal and maternal tissues and carcinogenesis in the offspring following a single transplacental dose of N-methyl-N-nitrosourea. Int J Cancer (1983) 0.78
[The effect of the irradiation of male mice on the sensitivity of 2 generations of progeny to the action of the skin tumor promoter 12-0-tetradecanoylphorbol-13-acetate]. Vopr Onkol (1991) 0.78
Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett (2001) 0.78
[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77
[Free-radical processes in blood serum, liver and large bowel during 1,2-dimethylhydrazine-induced carcinogenesis in rats]. Vopr Onkol (1997) 0.77
[Chromosomal damage in peripheral blood lymphocytes of rats in nitrosomethylurea-induced carcinogenesis]. Eksp Onkol (1990) 0.77
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
[Effect of radiation emitted from personal computer terminal on urethan-induced lung tumors in mice]. Vopr Onkol (1996) 0.77
[Dynamics of the transplacental penetration of 7,12-dimethylbenz(a)anthracene (DMBA) in mice]. Vopr Onkol (1973) 0.77
[Effects of radiation from video display terminals of personal computers on free radical processes in rats]. Biull Eksp Biol Med (1997) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
Role of age in host sensitivity to carcinogens. IARC Sci Publ (1983) 0.77
[Susceptibility of wild and knockout p53 FVB/N line mice to benz(a)pyrene-induced subcutaneous sarcoma]. Vopr Onkol (2002) 0.77
Microvascular endothelium dysfunction in rats bearing 1,2-dimethylhydrazine-induced colon tumors. Cancer Lett (1999) 0.77
[Effect of light regimens and melatonin on the homeostasis, life span and development of spontaneous tumors in female rats]. Adv Gerontol (2007) 0.77
[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77
[Melatonin suppresses benz(a)pyrene-induced carcinogenesis in mice]. Vopr Onkol (2007) 0.76
[Diethylnitrosamine-induced carcinogenesis in PARP-1(-/-) and PARP-1(+/+) mice]. Vopr Onkol (2009) 0.76
[Effect of light regimens and melatonin on homeostasis, life span and spontaneous tumorigenesis in male rats]. Vopr Onkol (2008) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76
[Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin]. Biull Eksp Biol Med (1980) 0.76
Increase with age in the hypothalamo-hypophyseal threshold to the inhibitory action of estrogens and the effect of pineal extract on this process. Bull Exp Biol Med (1974) 0.76
Hypothalamic mechanisms of ageing and of specific age pathology--III. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in energy systems. Exp Gerontol (1979) 0.76
[Colon carcinogenesis in rat vs. variable light]. Vopr Onkol (2008) 0.76
[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76
Long-live euthymic BALB/c-nu mice. I. Survival study suggests body weight as a life span predictor. Mech Ageing Dev (2001) 0.76
[Age-related characteristics of the effects of epithalamin on serotonin metabolism in the pineal gland of rats]. Biull Eksp Biol Med (1992) 0.76
Disturbances of diurnal rhythms of biogenic amines contents in hypothalamic nuclei as an evidence of neurotropic effects of enterotropic carcinogen 1,2-dimethylhydrazine. Neuro Endocrinol Lett (2001) 0.76
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76
Expression of circadian Per1 and Per2 genes in the liver and breast tumor tissues of HER2/neu transgenic mice of different age. Bull Exp Biol Med (2011) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76
[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76
[Effect of the enterotropic carcinogen 1,2-dimethylhydrazine on the level of biogenic amines in the hypothalamus of rats]. Biull Eksp Biol Med (1976) 0.76
Increase in lifespan of rats following polypeptide pineal extract treatment. Exp Pathol (Jena) (1979) 0.76
[Cancer risk in women: a possible connection with geographic and certain economic and social factors]. Vopr Onkol (2011) 0.76
[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76
Morphology of experimentally induced tumors of the sympathetic nervous system in rats. Exp Toxicol Pathol (2004) 0.76
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[Life span and tumor incidence in animals of various species]. Eksp Onkol (1987) 0.75
[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75
[Proto-oncogene expression in the liver of male rats of different age]. Biull Eksp Biol Med (1991) 0.75
[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75
[75th anniversary of the publication of N. N. Petrov's manual "A General Theory of Tumors"]. Vopr Onkol (1985) 0.75
[Comparative study of subcutaneous, rectal and peroral immunization with hormonal and nonhormonal proteins]. Patol Fiziol Eksp Ter (1978) 0.75
[Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up]. Vopr Onkol (1987) 0.75
[Effect of thyroxine, insulin and cholesterol on the amount of cyclic adenosine monophosphate in normal and oncornavirus infected cells]. Tsitologiia (1977) 0.75
[Cyclic adenosine monophosphate content in the lymphocytes of cancer patients]. Eksp Onkol (1985) 0.75
[Diurnal urine sodium and potassium concentration in lung cancer patients]. Vopr Onkol (1970) 0.75
[Adaptational and thyroid homeostasis and the state of fat and carbohydrate metabolism in lung cancer]. Vopr Onkol (1978) 0.75
[Endocrine changes in cancer of the rectum and colon]. Vopr Onkol (1987) 0.75
[Characteristics of the hormonal metabolic status of patients with colonic and rectal cancer]. Eksp Onkol (1988) 0.75
[Adenylate cyclase complex, lipids and the regulation of the hormonal sensitivity of tumor tissue]. Eksp Onkol (1986) 0.75
[Amplification of the heterologous response of adenylate cyclase in colonic tumors: relation to tissue lipid composition]. Vopr Med Khim (1988) 0.75
[Some functional characteristics of the genital system preceding the development of breast tumors]. Akush Ginekol (Mosk) (1973) 0.75
[Retrospective data on the weight of newborn infants in oncological patients]. Vopr Onkol (1973) 0.75
[Size and number of adipocytes in the perirenal fatty tissue in pregnancy and in the postpartum period in rats]. Biull Eksp Biol Med (1977) 0.75